business

Travere therapeutics director Timothy Coughlin sells $500,747 in stock

Investing.com · Jun 16, 2026, 8:55 PM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now? Yahoo Finance Another Hut 8 Board Member Sells Company Stock

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Travere therapeutics director Timothy Coughlin sells $500,747 in stock

Also covered by

More in business